Pembrolizumab Plus Chemotherapy in Metastatic Thymic Carcinoma: A Case Report.

Thomas, Quentin Dominique; Basse, Clémence; Luporsi, Marie; Girard, Nicolas

Thomas, Quentin Dominique; Basse, Clémence; Luporsi, Marie; Girard, Nicolas.

Afiliação

Thomas QD; Department of Medical Oncology, Montpellier Cancer institute (ICM), Montpellier, France.
Basse C; Oncogenic Pathways in Lung Cancer, Montpellier Cancer Research Institute (IRCM), University of Montpellier (UM), Montpellier, France.
Luporsi M; Department of Medical Oncology, Curie Montsouris Thorax Institute, Institut Curie, Paris, France.
Girard N; Department of Nuclear Medicine, Institut Curie, Paris, France.

Front Oncol ; 11: 814544, 2021.

Article em En | MEDLINE | ID: mdl-35127529

Palavras-chave

case report; immune checkpoint inhibitor (ICI); immunotherapy; therapeutic option; thoracic malignancies; thymic epithelial tumor (TET)

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Oncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google